b.next
b.next is a San Francisco biotechnology company building Nucleus, an open-source platform and toolkit for engineering synthetic cells and cell-free systems from scratch. Founded in 2023 by Anton Jackson-Smith, it works with university labs, governments and philanthropic funders to make synthetic-cell engineering shared rather than proprietary.
- Business model
- Biotech (synthetic cell platform + grants)
- Founders
- Anton Jackson-Smith
Sources: bnext.bio
1person interviewed
1episode across 1 show
The team on Day One
Hear from the team
More founder companies on Day One
Spot something wrong? Suggest a correction Updated 25 September 2026
